26 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
The document was signed by Anatoly Artamonov, Governor of Kaluga Region, Nikolay Polezhaev, Mayor of the City of Kaluga, Nikolay Milkis, General Director of the Kaluga Region Development Corporation, and Vladimir Gurdus, General Director of D-Pharma, which is managing the NovaMedica project.
The new plant will be built under a joint venture between Domain Associates LLC, one of the leading American venture capital funds, which specializes in pharmaceuticals, and RUSNANO, a Russian government-owned investment company.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
Federal project to combat hepatitis C will be launched in 2025
01 November 2024
Domestic drugs now make up 60% of Russian pharmacies
01 November 2024
Novel nanoemulsion-based delivery of antimycobacterial drug
31 October 2024
Russia will create a National Center for Genetic Resources of Microorganisms
31 October 2024